ARTICLE | Distillery Therapeutics
Hematology
August 29, 2017 6:04 PM UTC
Mouse studies suggest depleting NK cells or inhibiting NK cell activation could help treat fetal/neonatal alloimmune thrombocytopenia (FNAIT). In a mouse model of FNAIT, a tool antibody that depletes ...